CPE (formerly CITIC Private Equity) is a Chinese alternative investment firm headquartered in Beijing. Spun off from CITIC Securities in 2018, the firm manages approximately US$14 billion in total AUM across technology, industrial, consumer, healthcare, and infrastructure sectors. Its latest individual private equity fund (Fund IV) targeted US$3 billion.
They made 1 investment in the last 12 months. Average disclosed round size is $572.7M (across 15 rounds with reported amounts).
Portfolio
14
Fund Size
$3B
Top Stage
Series C
Last 12 Mo
1
Team
MM
Mark Mao
Managing Director
MG
Michael Guan
Head of Europe, CPE
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
18 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| KKling AI | Unknown | $2.8B | Jul 2026 |
| SSangon Biotech | Unknown | $290M | Jan 2023 |
| EEnflame Technology | Series C | — | Jan 2022 |
 Exegenesis Bio | Series B | $50M | Jun 2021 |
 Insilico Medicine | Series C | $255M | Jun 2021 |
 Insilico Medicine | Series C | $255M | Jun 2021 |
| HHesai | Series D | $300M | Jun 2021 |
 Triastek | Series B | $100M | Jan 2021 |
 Plus.ai | Unknown | $200M | Jan 2021 |
| EEnflame Technology | Series C | — | Jan 2021 |
 Yuanfudao | Series G | $2.2B | Oct 2020 |
 MicroPort | Unknown | $130M | Apr 2020 |
| HHesai | Series D | $370M | Jan 2020 |
 JAKA Robotics | Series C | — | Jan 2019 |
| Yuanfudao | Growth | $300M | Dec 2018 |
 17zuoye | Series E | $250M | Mar 2018 |
 4Paradigm | Series D | $700M | — |
| Insilico Medicine | Growth | $400M | — |
Top Co-Investors
Lake Bleu Capital5 shared
Warburg Pincus LLC5 shared
Hillhouse Investment5 shared
Baidu Ventures3 shared
Sinovation Ventures3 shared
Mirae Asset3 shared
Bold Capital Partners3 shared
B Capital3 shared
OrbiMed3 shared
Eight Roads3 shared
Lightspeed Venture Partners3 shared
Deerfield3 shared
HongShan3 shared
Greenwoods Asset Management3 shared
Boyu Capital3 shared
Primavera Capital Group3 shared
Qiming Venture Partners USA2 shared
LAV2 shared
Nexus Venture Partners2 shared
Last updated: 7 October 2026